KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Return on Capital Employed: 2011-2024

Historic Return on Capital Employed for Emergent BioSolutions (EBS) over the last 14 years, with Dec 2024 value amounting to -0.08%.

  • Emergent BioSolutions' Return on Capital Employed rose 20.00% to 0.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.09%, marking a year-over-year increase of 20.00%. This contributed to the annual value of -0.08% for FY2024, which is 32.00% up from last year.
  • Latest data reveals that Emergent BioSolutions reported Return on Capital Employed of -0.08% as of FY2024, which was up 80.90% from -0.39% recorded in FY2023.
  • Over the past 5 years, Emergent BioSolutions' Return on Capital Employed peaked at 0.20% during FY2020, and registered a low of -0.39% during FY2023.
  • Its 3-year average for Return on Capital Employed is -0.19%, with a median of -0.09% in 2022.
  • Per our database at Business Quant, Emergent BioSolutions' Return on Capital Employed decreased by 30bps in 2023 and then spiked by 32bps in 2024.
  • Emergent BioSolutions' Return on Capital Employed (Yearly) stood at 0.20% in 2020, then dropped by 6bps to 0.13% in 2021, then decreased by 23bps to -0.09% in 2022, then dropped by 30bps to -0.39% in 2023, then soared by 32bps to -0.08% in 2024.